Actuate Therapeutics Inc (ACTU)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD ($) | |||
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -7.77M | -5.44M | -5.39M |
| Pre Tax Income | -8.3M | -6.57M | -5.97M |
| Net Income | -8.3M | -6.57M | -5.97M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 |
| EBIT | -7.77M | -5.44M | -5.39M |
| EBITDA | -7.77M | -5.44M | -5.39M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -24.97M |
| Pre Tax Income | -24.75M |
| Net Income | -24.75M |
| Preferred Dividends | 0 |
| Basic Earnings Per Share (EPS) | -8.132 |
| EBIT | -24.97M |
| EBITDA | -24.97M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
